Lithium is a key component of the electric vehicle battery market. This has led to a surge in demand. This imbalance in demand and supply has resulted in record-breaking lithium prices that have caused some stocks to trade for high valuations. Albemarle Livent (NYSE.:) (NYSE.:) is a lithium stock that we feel looks overvalued at current price levels. Keep reading. There is no stopping the demand for lithium. Because lithium is an essential component of electric vehicles (EVs), the demand for it has risen almost in tandem with the rising demand. Record-breaking lithium prices have been a result of the increased demand.

The lithium price is expected to stay high due to supply limitations that are predicted to continue into 2022. According to an S&P Global Market Intelligence forecast, lithium supply will rise to 636,000 MT from an estimated supply of 497,000 MT in 2021, while lithium demand in 2022 will be 641,000 MT LCE, up from an estimated 504,000 MT in 2021, which indicates that there will be a 5,000 MT LCE supply deficit in 2022. Due to the shortage of lithium, interest has risen in alternative lithium-ion batteries such as graphene supercapacitors and solid-state batteries.

In this environment, it might be smart to stay away from lithium stocks Albemarle Corporation and Livent Corporation. Their current prices make them look exaggerated. Analysts have also recently downgraded their value.

Continue reading on StockNews